In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they plan to reclassify cannabis as being a Routine III drug. This rescheduling will acknowledge that cannabis has legitimate health-related applications and will help open the door to investigate on other potential remedy works by using.The crew at Medterra is also top-of-the-p